Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:699-703

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franchini, K. G.
Right arrow Articles by Krieger, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franchini, K. G.
Right arrow Articles by Krieger, E. M.

(Hypertension. 1997;30:699.)
© 1997 American Heart Association, Inc.


Articles

Hemodynamics of Chemoreflex Activation in Unanesthetized Rats

Kleber G. Franchini; Vera L. L. Oliveira; Eduardo M. Krieger

From the Hypertension Unit, Heart Institute, University of São Paulo, São Paulo, Brazil.

Correspondence to Dr Eduardo M. Krieger, Hypertension Unit, Heart Institute, University of São Paulo, Av Dr Enéas de Carvalho Aguiar, 44, 05403-000 São Paulo, Brazil.

Abstract Experiments were performed on unanesthetized rats (n=6) to determine the systemic hemodynamics during chemoreflex activation by intravenous KCN. Rats chronically instrumented with ultrasonic flow probes in the ascendant aorta were submitted to KCN injections (30 µg/kg) before and after sequential administration of the autonomic blockers atropine and propranolol. In the control period KCN injections produced a 60% reduction in heart rate (HR) and a 46% elevation in blood pressure (BP), while cardiac output (CO) decreased 76%, stroke volume (SV) decreased 40%, and calculated total peripheral resistance (TPR) increased 900%. Atropine administration increased resting HR, whereas no change was observed in CO or BP. Chemoreflex-induced bradycardia was markedly attenuated (26%), and the pressor response was potentiated (59%) after atropine administration. CO and TPR responses were both attenuated after atropine administration (68% and 718%, respectively). Sequential administration of propranolol decreased HR but did not change the cardiovascular responses to KCN injections compared with the responses observed after atropine administration. In conclusion, CO is greatly reduced during KCN-evoked chemoreflex. Besides the intense bradycardia, a decrease in SV contributed to this reduction. Bradycardic response was most dependent on the cardiac parasympathetic activation, and the reduction in SV was probably most dependent on the increased cardiac afterload due to the sudden increase in BP.


Key Words: chemoreflex • cardiovascular control • blood pressure • hemodynamics




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. F. Hayward and M. Von Reitzenstein
c-Fos expression in the midbrain periaqueductal gray after chemoreceptor and baroreceptor activation
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1975 - H1984.
[Abstract] [Full Text] [PDF]